The reflection of peripheral blood expression of these genes in solid tumor patients may serve to further establish these genes as potential circulating biomarker for cancer prognosis and therefore by attributing the functional significance of HIF-1α, MDR1 and LAPTM4B, addition of angiogenic inhibitors coupled with autophagy inhibitors may synergistically aid in the effective therapy and prevent drug resistance. Here, HIF1A is linked to cancer.